NewGLab Pharma Co Ltd
KOSDAQ:214870
Gross Margin
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Peer Comparison
| Country | Company | Market Cap |
Gross Margin |
||
|---|---|---|---|---|---|
| KR |
N
|
NewGLab Pharma Co Ltd
KOSDAQ:214870
|
439.9m KRW |
Loading...
|
|
| JP |
|
Keyence Corp
TSE:6861
|
12.9T JPY |
Loading...
|
|
| CN |
|
Hangzhou Hikvision Digital Technology Co Ltd
SZSE:002415
|
300.1B CNY |
Loading...
|
|
| US |
|
Keysight Technologies Inc
NYSE:KEYS
|
39.4B USD |
Loading...
|
|
| US |
|
Teledyne Technologies Inc
NYSE:TDY
|
30.3B USD |
Loading...
|
|
| SE |
|
Hexagon AB
STO:HEXA B
|
255.8B SEK |
Loading...
|
|
| CN |
|
Zhonghang Electronic Measuring Instruments Co Ltd
SZSE:300114
|
193.2B CNY |
Loading...
|
|
| UK |
|
Halma PLC
LSE:HLMA
|
13.4B GBP |
Loading...
|
|
| US |
|
Trimble Inc
NASDAQ:TRMB
|
15.8B USD |
Loading...
|
|
| TW |
|
Chroma ATE Inc
TWSE:2360
|
412.6B TWD |
Loading...
|
|
| US |
|
Zebra Technologies Corp
NASDAQ:ZBRA
|
12.7B USD |
Loading...
|
Market Distribution
| Min | -646.5% |
| 30th Percentile | 12.8% |
| Median | 19.7% |
| 70th Percentile | 32.2% |
| Max | 54 001.3% |
Other Profitability Ratios
NewGLab Pharma Co Ltd
Glance View
NewGLAB Pharma Co., Ltd. engages in the manufacture of closed-circuit television camera and equipment. The company is headquartered in Bucheon, Gyeonggi-Do. The company went IPO on 2015-10-13. The firm's product portfolio consists of general analog cameras that used for CCTVs, high definition (HD) analog cameras, HD-serial digital interface (SDI) cameras, extend (EX)-SDI cameras, internet protocol (IP) cameras that used for network CCTVs, digital video recorders (DVRs) that used for image storage devices, network video recorders (NVRs) and others. In addition, the Company is involved in the business of 5G smartphone distribution. The firm distributes its products within domestic market and to overseas markets.
See Also
Gross Margin is calculated by dividing the Gross Profit by the Revenue.
The current Gross Margin for NewGLab Pharma Co Ltd is 2.2%, which is below its 3-year median of 4%.
Over the last 3 years, NewGLab Pharma Co Ltd’s Gross Margin has decreased from 11.4% to 2.2%. During this period, it reached a low of -13.2% on Sep 30, 2024 and a high of 17.3% on Sep 30, 2022.
